SynAct Pharma (STO: SYNACT)

Last close As at 28/02/2026

SEK19.70

0.10 (0.51%)

Market capitalisation

SynAct Pharma is a clinical-stage biotechnology company focussed on the development of treatments to resolve, rather than inhibit, ongoing inflammatory processes in acute and chronic diseases.

Latest Insights

View More

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Jeppe Øvlesen

    CEO

  • Malin Wikstrand

    Interim CFO